Synthesis and biological evaluation of an anticancer vaccine containing the C-glycoside analogue of the Tn epitope

Francesco Peri, Laura Cipolla, Maria Rescigno, Barbara La Ferla, Francesco Nicotra

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

The C-saccharide analogue of the GalNAc (Tn epitope) has been covalently linked to the T cell epitope peptide OVA using a chemoselective convergent synthetic approach. In this way, a nonhydrolyzable synthetic vaccine was obtained composed by a B epitope conjugated to a T cell epitope. This compound was tested in a proliferation assay with spleen cells from DO11.10 mice. The molecule was recognized by transgenic T cells although at a slightly lower efficiency if compared with the reference peptide OVA. An additional experiment with dendritic cells fixed with glutaraldehyde shows that the glycopeptide can bind to extracellular MHC molecules without need of internalization and processing and that the C-glycoside part does not interfere with TCR recognition. These observations constitute an important starting point for the use of this molecule as vaccine against the Tn-expressing TA3-Ha mouse mammary carcinoma.

Original languageEnglish
Pages (from-to)325-328
Number of pages4
JournalBioconjugate Chemistry
Volume12
Issue number3
DOIs
Publication statusPublished - May 2001

Fingerprint

Epitopes
Glycosides
T-Lymphocyte Epitopes
Vaccines
T-cells
Peptides
Synthetic Vaccines
Molecules
Glycopeptides
Glutaral
Dendritic Cells
Spleen
Breast Neoplasms
T-Lymphocytes
Assays
Processing
C-glycoside
Experiments

ASJC Scopus subject areas

  • Chemistry(all)
  • Organic Chemistry
  • Clinical Biochemistry
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry

Cite this

Synthesis and biological evaluation of an anticancer vaccine containing the C-glycoside analogue of the Tn epitope. / Peri, Francesco; Cipolla, Laura; Rescigno, Maria; La Ferla, Barbara; Nicotra, Francesco.

In: Bioconjugate Chemistry, Vol. 12, No. 3, 05.2001, p. 325-328.

Research output: Contribution to journalArticle

Peri, Francesco ; Cipolla, Laura ; Rescigno, Maria ; La Ferla, Barbara ; Nicotra, Francesco. / Synthesis and biological evaluation of an anticancer vaccine containing the C-glycoside analogue of the Tn epitope. In: Bioconjugate Chemistry. 2001 ; Vol. 12, No. 3. pp. 325-328.
@article{9e999b80c8d14e8f83ed4019f623a0ed,
title = "Synthesis and biological evaluation of an anticancer vaccine containing the C-glycoside analogue of the Tn epitope",
abstract = "The C-saccharide analogue of the GalNAc (Tn epitope) has been covalently linked to the T cell epitope peptide OVA using a chemoselective convergent synthetic approach. In this way, a nonhydrolyzable synthetic vaccine was obtained composed by a B epitope conjugated to a T cell epitope. This compound was tested in a proliferation assay with spleen cells from DO11.10 mice. The molecule was recognized by transgenic T cells although at a slightly lower efficiency if compared with the reference peptide OVA. An additional experiment with dendritic cells fixed with glutaraldehyde shows that the glycopeptide can bind to extracellular MHC molecules without need of internalization and processing and that the C-glycoside part does not interfere with TCR recognition. These observations constitute an important starting point for the use of this molecule as vaccine against the Tn-expressing TA3-Ha mouse mammary carcinoma.",
author = "Francesco Peri and Laura Cipolla and Maria Rescigno and {La Ferla}, Barbara and Francesco Nicotra",
year = "2001",
month = "5",
doi = "10.1021/bc000143a",
language = "English",
volume = "12",
pages = "325--328",
journal = "Bioconjugate Chemistry",
issn = "1043-1802",
publisher = "American Chemical Society",
number = "3",

}

TY - JOUR

T1 - Synthesis and biological evaluation of an anticancer vaccine containing the C-glycoside analogue of the Tn epitope

AU - Peri, Francesco

AU - Cipolla, Laura

AU - Rescigno, Maria

AU - La Ferla, Barbara

AU - Nicotra, Francesco

PY - 2001/5

Y1 - 2001/5

N2 - The C-saccharide analogue of the GalNAc (Tn epitope) has been covalently linked to the T cell epitope peptide OVA using a chemoselective convergent synthetic approach. In this way, a nonhydrolyzable synthetic vaccine was obtained composed by a B epitope conjugated to a T cell epitope. This compound was tested in a proliferation assay with spleen cells from DO11.10 mice. The molecule was recognized by transgenic T cells although at a slightly lower efficiency if compared with the reference peptide OVA. An additional experiment with dendritic cells fixed with glutaraldehyde shows that the glycopeptide can bind to extracellular MHC molecules without need of internalization and processing and that the C-glycoside part does not interfere with TCR recognition. These observations constitute an important starting point for the use of this molecule as vaccine against the Tn-expressing TA3-Ha mouse mammary carcinoma.

AB - The C-saccharide analogue of the GalNAc (Tn epitope) has been covalently linked to the T cell epitope peptide OVA using a chemoselective convergent synthetic approach. In this way, a nonhydrolyzable synthetic vaccine was obtained composed by a B epitope conjugated to a T cell epitope. This compound was tested in a proliferation assay with spleen cells from DO11.10 mice. The molecule was recognized by transgenic T cells although at a slightly lower efficiency if compared with the reference peptide OVA. An additional experiment with dendritic cells fixed with glutaraldehyde shows that the glycopeptide can bind to extracellular MHC molecules without need of internalization and processing and that the C-glycoside part does not interfere with TCR recognition. These observations constitute an important starting point for the use of this molecule as vaccine against the Tn-expressing TA3-Ha mouse mammary carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=0035023854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035023854&partnerID=8YFLogxK

U2 - 10.1021/bc000143a

DO - 10.1021/bc000143a

M3 - Article

C2 - 11353527

AN - SCOPUS:0035023854

VL - 12

SP - 325

EP - 328

JO - Bioconjugate Chemistry

JF - Bioconjugate Chemistry

SN - 1043-1802

IS - 3

ER -